← Back to headlines
MacroGenics Stock Slips After Early-Stage Trial Data Release
MacroGenics shares experienced a decline following the release of early-stage trial data for its leading asset.
24 Jul, 15:27 — 24 Jul, 15:27
Sources
Showing 1 of 1 sources
